Southborough, MA, June 28, 2017 – Amorsa Therapeutics, Inc., a neuropharmaceutical company pioneering the development of breakthrough treatments for nervous system disorders today announced that the company was featured in the June issue of Life Science Leader magazine. Please click here to view the article.
About Amorsa Therapeutics
Amorsa is an early-stage, neuropharmaceutical company pioneering the development and commercialization of breakthrough treatments for nervous system disorders including moderate-to-severe pain and treatment-resistant depression. Founded in 2013, Amorsa has assembled a leadership team with experience in building several successful life science companies and has a strong track record in developing novel therapeutic treatments. In addition, Amorsa has attracted leading neuroscience and pain management experts to join its Scientific and Clinical Advisory Board. For more information, visit www.amorsatx.com.
About Life Science Leader Magazine
Life Science Leader magazine is a publication intended to help facilitate connections and foster collaborations in pharmaceutical and medical device developments to find ways to get more life-saving and life-improving therapies to market in an efficient manner. The publication has a circulation of 25,000 professionals in the life sciences, pharmaceutical, biopharmaceutical, and medical device industries.